Literature DB >> 11665464

[Common cold--risk factors, transmission and treatment].

H Herløv-Nielsen1, H Permin.   

Abstract

The common cold is the most prevalent disease in humans. It is generally caused by rhinovirus. Bacterial involvement is rare, and an uncomplicated common cold does not require treatment with antibiotics. The symptoms are not caused by tissue destruction, but rather by the response of the immune system, including the release of kinins and interleukins. The intensity of transmission depends upon the amount of nasal discharge. It is mediated in part by the hands (sometimes via contaminated objects) and partly by aerosols. Rhinovirus is involved in 40% of asthma attacks in school children, and in about 60% of exacerbations in adults with chronic obstructive pulmonary disease. Smoking, stress, and a few types of social contact are all risk factors, whereas alcohol consumption seems to be protective. Exposure to a cold environment is probably of no significance in the pathogenesis. No effective cure is known. The medications in use are all directed exclusively against the symptoms, and especially for pre-school children, they are of doubtful value and potentially harmful.

Entities:  

Mesh:

Year:  2001        PMID: 11665464

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  3 in total

1.  Efficacy and Safety of Ganduqing Granules in Treating the Common Cold: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yilan Wang; Piao Zhou; Yuxiao Wu; Huaqin Cao; Wenfeng Hao; Fei Wang; Jing Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-09       Impact factor: 2.650

2.  The efficacy and safety of Baoji Tablets for treating common cold with summer-heat and dampness syndrome: study protocol for a randomized controlled trial.

Authors:  Rui-zhi Feng; Jian-qin Lv; Angela K Johnson; Juan D Montoya; Bing Mao
Journal:  Trials       Date:  2013-12-21       Impact factor: 2.279

Review 3.  The common cold: potential for future prevention or cure.

Authors:  Maria Passioti; Paraskevi Maggina; Spyridon Megremis; Nikolaos G Papadopoulos
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.